curacle co.,ltd. (KOSDAQ:365270)
South Korea · Delayed Price · Currency is KRW 12,110
-310 (-2.50%)
At close: Feb 6, 2026
curacle co.,ltd. Market Cap
curacle co.,ltd. has a market cap or net worth of 256.21 billion as of February 6, 2026. Its market cap has increased by 199.78% in one year.
Market Cap
256.21B
Enterprise Value
241.19B
Revenue
1.14B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,110.00
Market Cap Chart
Since July 22, 2021, curacle co.,ltd.'s market cap has decreased from 409.36B to 256.21B, a decrease of -37.41%. That is a compound annual growth rate of -9.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 256.21B | 71.04% |
| Dec 30, 2025 | 149.80B | 79.35% |
| Dec 30, 2024 | 83.52B | -48.17% |
| Dec 28, 2023 | 161.14B | 2.54% |
| Dec 29, 2022 | 157.15B | -49.31% |
| Dec 30, 2021 | 310.02B | -24.27% |
| Jul 22, 2021 | 409.36B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GC Cell | 381.69B |
| NIBEC | 368.79B |
| Y-Biologics | 359.72B |
| ABION | 327.97B |
| Genome & Company | 292.36B |
| Vaxcell-Bio Therapeutics | 229.78B |
| ISU Abxis | 225.98B |
| Prestige Biologics | 224.32B |